ABIVAX Société Anonyme (LON:0RA9)
London
· Delayed Price · Currency is GBP · Price in EUR 7.42
-0.01 (-0.13%)
Feb 21, 2025, 3:47 PM BST
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of 399.76 million as of February 21, 2025. Its market cap has decreased by -34.04% in one year.
Market Cap
399.76M
Enterprise Value
309.68M
Revenue
7.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.42
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from 143.21M to 399.76M, an increase of 179.15%. That is a compound annual growth rate of 11.21%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 179.71B |
| GSK plc | 59.06B |
| Haleon | 34.94B |
| Smith & Nephew | 8.87B |
| Hikma Pharmaceuticals | 5.06B |
| ConvaTec Group | 4.94B |
| HUTCHMED (China) | 2.06B |
| Oxford Nanopore Technologies | 1.26B |